Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 1/4 earnings.... One thing to watch....

I read your post and thought a verified, iron-clad, no-doubt, signed and dated patent validation by USPTO is going to be more powerful and meaningful than any quarter report. With all that has gone on this quarter to generate leagal fees, consulting fees(Baroni) and licenses (which may have been lower just to grease the financial wheels) the pay to the board and their travel expenses and what ever else that I may have overlooked I am not thinking big numbers for this quarter report. However, I am thinking that news about a new CEO and board additions or changes and implimentation of Baroni's review and a few contracts will be the driving factors. I am also thinking any surprises like spin offs and buy outs and capital investments/funding by well known companies or individuals will be additional factors to move the share price. If there ever was a time that PTSC had so many factors at play to move the share price I can't recall it! GLTAL

Share
New Message
Please login to post a reply